Radiant Energy Corporation
TSX VENTURE : RDT

Radiant Energy Corporation

August 21, 2007 08:56 ET

Radiant Provides Update on Infrared Deicing Systems for US Air Mobility Command

PORT COLBORNE, ONTARIO--(Marketwire - Aug. 21, 2007) - Radiant Energy Corporation ("Radiant" or the "Company") (TSX VENTURE:RDT) developer and marketer of InfraTek®, the environmentally friendly, patented, infrared pre-flight aircraft deicing system, announced the successful completion of the in-lab infrared material testing on select US military aircraft materials. The Company also announced that due to a change in shareholder composition of Radiant Energy, the United States Department of Defense is not permitted to further fund research into the transportable deicing system.

Successful in-lab test results

The in-lab infrared testing was conducted with The Boeing Company's (Boeing) Advance Global Mobility Systems Division acting through the United States Air Force (USAF) Environmental funding for the C-17 aircraft materials to accomplish life cycle infrared exposure testing. The life cycle in-lab testing on various materials was a success. No parts were heated to rates in excess of the guidelines provided by Boeing for the C-17 aircraft. Aircraft samples were returned to Boeing for more detailed analysis. Site testing is planned for late October or early November 2007 at the InfraTek facility at JFK International Airport in New York. This materials testing and subsequent aircraft validation at the JFK InfraTek facility will provide the Air Force needed data to approve the use of InfraTek's technology for C-17s and may lead to a blanket validation for the other aircraft flown by the United States Air Force and other US Military departments.

Development of an Infrared transportable system

On January 30, 2007, the Company announced it's wholly owned subsidiary, Radiant Aviation Services, Inc., was awarded a Phase II under the U.S. Department of Defense's Small Business Innovation Research ('SBIR") program for the development of a non-glycol based, transportable deicing system for use by the US military in remote theaters of operation, subject to entering a firm contract. In recent years, due to the conversion of certain debt instruments and new investment in common shares primarily by Canadian citizens, the percentage of common shares held by US Citizens was significantly reduced to levels unacceptable under the SBIR guidelines therefore the Company could not enter a contract with the Department of Defense to continue on with Phase II under the SBIR program.

Under Phase I, Radiant successfully demonstrated the deicing effect with an electrically powered array at the National Gas Test Center in Montreal, Canada. Radiant now owns the technology for electric heating units and the Company has several options to pursue to continue with the prototype development and to build a full scale technology demonstration. The Company can seek funding under other US Government programs, seek funding programs provided by the Canadian Government, or raise private equity to complete the development. Revenue from the transportable system is not expected for at least 3 to 5 years.

The proposed infrared transportable system is not a replacement technology to the existing patented InfraTek deicing system. A delay in the development of the transportable system will not affect the validation process on the C-17 for Air Mobility Command and future potential sales of the Company's InfraTek fixed base deicing technology to the US military.

Radiant trades on the TSX Venture Exchange (symbol RDT). The InfraTek Deicing System is the only FAA-approved for use, non-glycol based alternative to the conventional pre-flight ground deicing process. InfraTek offers savings to airports and airlines by reducing treatment costs and by significantly reducing the negative environmental impact of glycol.

This press release may contain forward-looking statements, including statements regarding the business and anticipated financial performance of Radiant Energy Corporation, which involve risks and uncertainties. These risks and uncertainties may cause Radiant's actual results to differ materially from those contemplated by the forward-looking statements.

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

Contact Information